United Therapeutics Corp. (UTHR) PT Raised to $148 at Leerink Partners
Leerink Partners raised its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $148.00 (from $127.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
